Delivery Order SPE2DB20D3103-SPE2DB23FP3T5
Award Date 8/15/23
Potential Completion Date 9/6/23
Potential Value $6.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,042.76 firm fixed-price delivery order is for the supply of Veklury (Remdesivir) 100 mg vials, a key therapeutic used to treat COVID-19. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen, a large pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veklury (remdesivir) 100 mg vials valued at $15,848.80 under a firm fixed-price contract. The award was issued on August 28, 2025, with an ultimate completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply...
- This federal contract award, valued at $8,511.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Veklury (Remdesivir) 100 mg vials, a specialty pharmaceutical used for the treatment of COVID-19. The contract is a firm-fixed-price delivery order with a completion date of February 6, 2024. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,754.64, is for the delivery of the drug VEKLURY (Remdesivir) 100 mg vials. It is a firm fixed-price contract with a completion date of June 2, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award, valued at $34,017.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract involves the delivery of Veklury (Remdesivir) 100 mg vials, a critical medication used for the treatment of COVID-19. This contract does not have any set-aside designations, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the antiviral drug VEKLURY (Remdesivir) in 100 mg vials. The $2,042.76 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency (DLA) awarded a $12,903.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 8, 2026, for the supply of Veklury 100 mg vials, with a completion deadline of January 30, 2026. This non-set-aside competitive award represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical supply vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Veklury (remdesivir) 100 mg vials, with a ceiling value of $5,010.48 and an ultimate completion date of December 1, 2025. This is a firm fixed-price delivery order awarded without set-aside designation, indicating competitive award based on the vendor's demonstrated capability to fulfill federal pharmaceutical procurement requirements. The place of performance is...
- The Defense Logistics Agency awarded a $8,602.20 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Veklury on January 8, 2026, with an ultimate completion date of January 30, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government healthcare...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of 100 milligram vials of the COVID-19 treatment medication Veklury (Remdesivir) with a potential value of $13,618.40 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical...